Sartorius Stedim Biotech Stock
Stocks
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Euronext Paris
20:55:00 18/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 226.80 EUR | +1.16% |
|
0.00% | +8.00% |
| 10-26 | Sartorius Stedim Biotech : Jefferies reiterates its Buy rating | ZD |
| 10-23 | Sartorius Stedim Biotech : JP Morgan maintains a Buy rating | ZD |
| Market Cap | 22.07B 24.2B 20.4B 18.41B 34.68B 2,261B 36.04B 246B 97.41B 1,220B 90.77B 88.87B 3,854B | P/E 2026 * |
57.7x | P/E 2027 * | 44.1x |
|---|---|---|---|---|---|
| Enterprise Value | 24.06B 26.38B 22.25B 20.08B 37.81B 2,465B 39.3B 269B 106B 1,331B 98.98B 96.9B 4,202B | EV / Sales 2026 * |
7.68x | EV / Sales 2027 * | 6.83x |
| Free-Float |
28.47% | Yield 2026 * |
0.36% | Yield 2027 * | 0.44% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| DIM | Real-time | |
| DIMp | Real-time | ||
| 56S1 | Delayed | ||
| 56S1 | Real-time | ||
| SDMHF | Delayed | ||
| 56S1 | Delayed | ||
| 0NK7 | Delayed | ||
| 0NK7 | Real-time | ||
| 56S1 | Real-time | ||
| 56S1 | Delayed | ||
| 4DIM | End-of-day quote | ||
| DIM | End-of-day quote |
Last Transcript: Sartorius Stedim Biotech
| 1 day | +1.16% | ||
| Current month | +1.52% | ||
| 1 month | +5.49% | ||
| 3 months | +25.65% | ||
| 6 months | +43.09% | ||
| Current year | +8.00% |
| 1 week | 222.2 | 228.8 | |
| 1 month | 208 | 229.8 | |
| Current year | 150 | 229.8 | |
| 1 year | 150 | 229.8 | |
| 3 years | 139.1 | 281 | |
| 5 years | 139.1 | 544 | |
| 10 years | 50.13 | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 28/03/2023 |
| Chief Tech/Sci/R&D Officer | 62 | 08/09/2011 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 07/04/2015 | |
Susan Dexter
BRD | Director/Board Member | 70 | 07/04/2015 |
Lothar Kappich
BRD | Director/Board Member | 69 | 14/09/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/12/25 | Sell | Company | 750,000 | 0.7706% | ||
| 16/02/24 | Buy | Chief Executive Officer | 1,716,739 | 1.8624% | ||
| 02/03/22 | Sell | Company | 200,442 | 0.2174% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.16% | 0.00% | +21.58% | +13.29% | 24.03B | ||
| -0.22% | -4.40% | -19.63% | +4.95% | 181B | ||
| -1.56% | -0.88% | -0.08% | +34.72% | 125B | ||
| +0.19% | -0.20% | -11.51% | +10.32% | 121B | ||
| +1.12% | -0.96% | -41.94% | +0.79% | 90.52B | ||
| -0.64% | -0.45% | -3.69% | +78.62% | 66.9B | ||
| +0.31% | +0.73% | +12.35% | -7.37% | 58.68B | ||
| +1.19% | -0.59% | +4.22% | +50.63% | 54.38B | ||
| +0.77% | -1.76% | +3.79% | +42.73% | 48.46B | ||
| +0.84% | +4.77% | +3.97% | -0.26% | 35.4B | ||
| Average | +0.32% | -0.34% | -3.09% | +22.84% | 81B | |
| Weighted average by Cap. | +0.03% | -1.09% | -8.94% | +20.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13B 3.44B 2.9B 2.61B 4.92B 321B 5.12B 34.99B 13.83B 173B 12.89B 12.62B 547B | 3.48B 3.82B 3.22B 2.91B 5.48B 357B 5.69B 38.91B 15.38B 193B 14.33B 14.03B 609B |
| Net income | 384M 421M 355M 320M 603M 39.34B 627M 4.29B 1.69B 21.23B 1.58B 1.55B 67.05B | 489M 537M 452M 408M 769M 50.14B 799M 5.46B 2.16B 27.06B 2.01B 1.97B 85.45B |
| Net Debt | 1.99B 2.19B 1.84B 1.66B 3.13B 204B 3.26B 22.27B 8.8B 110B 8.2B 8.03B 348B | 1.74B 1.91B 1.61B 1.45B 2.74B 179B 2.85B 19.47B 7.7B 96.42B 7.17B 7.02B 304B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/11/26 | €226.80 | +1.16% | 52,211 |
| 17/11/26 | €224.20 | -0.44% | 67,748 |
| 16/11/26 | €225.20 | +0.90% | 55,548 |
| 13/11/26 | €223.20 | +0.18% | 56,546 |
| 12/11/26 | €222.80 | -1.76% | 75,780 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions




















